NCT04669145

Brief Summary

To identify the benefits from regional anesthesia use as pain management in the pediatric population by delineating the differences in efficacy of continuous nerve blockade versus single-shot techniques after pediatric orthopaedic limb procedures. By doing this, the investigators can determine if specific anesthetic techniques should become a standard of care in pain management for the pediatric population and supersede the need for opioid medication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Jun 2021

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 16, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

June 24, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2024

Completed
Last Updated

July 29, 2025

Status Verified

July 1, 2025

Enrollment Period

2.8 years

First QC Date

December 6, 2020

Last Update Submit

July 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Opioid Consumption

    Amount of opioid medications taken for pain control.

    For first 48 hours post-operatively.

Secondary Outcomes (20)

  • Opioid Consumption

    Through 12 hours post-operatively.

  • Opioid Consumption

    Through 24 hours post-operatively.

  • Opioid Consumption

    Through 36 hours post-operatively.

  • Opioid Consumption

    Through 48 hours week post-operatively.

  • Opioid Consumption

    Through 72 hours post-operatively.

  • +15 more secondary outcomes

Study Arms (4)

Continuous Regional Anesthesia Lower Limb Surgery

EXPERIMENTAL

Various types of regional anesthesia blocks will be performed based on the patient's injuries including fascia iliaca plane blocks, femoral nerve blocks, adductor canal blocks, popliteal approach sciatic nerve blocks, and saphenous nerve blocks A catheter will be placed for the given block for 48 hours. Those patients undergoing lower limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.

Drug: Ropivacaine

Single Shot Regional Anesthesia Lower Limb Surgery

EXPERIMENTAL

Various types of regional anesthesia blocks will be performed based on the patient's injuries including fascia iliaca plane blocks, femoral nerve blocks, adductor canal blocks, popliteal approach sciatic nerve blocks, and saphenous nerve blocks. These blocks will be given via a single dose or "single shot". Those patients undergoing lower limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.

Drug: Ropivacaine

Continuous Regional Anesthesia Upper Limb Surgery

EXPERIMENTAL

Various types of regional anesthesia blocks involving the brachial plexus will be performed based on the patient's injuries. A catheter will be placed for the given block for 48 hours. Those patients undergoing upper limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.

Drug: Ropivacaine

Single Shot Regional Anesthesia Upper Limb Surgery

EXPERIMENTAL

Various types of regional anesthesia blocks involving the brachial plexus will be performed based on the patient's injuries. A catheter will be placed for the given block for 48 hours. Those patients undergoing upper limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.

Drug: Ropivacaine

Interventions

Dosing and volume will vary based on type of block used and weight of patient because of the pediatric population in the study.

Continuous Regional Anesthesia Lower Limb SurgeryContinuous Regional Anesthesia Upper Limb SurgerySingle Shot Regional Anesthesia Lower Limb SurgerySingle Shot Regional Anesthesia Upper Limb Surgery

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients undergoing primary orthopaedic limb surgery
  • Outpatient orthopaedic surgeries
  • Patients undergoing orthopaedic surgery who would normally receive regional anesthesia

You may not qualify if:

  • Patients younger than 5 years of ago or older than 18 years of age
  • Revision orthopaedic surgeries
  • Spinal orthopaedic surgeries
  • Orthopaedic surgeries where the standard of care for type of regional anesthesia has been established (continuous regional for ACL reconstruction)
  • Patients with the inability to articulate pain scores
  • Inpatient orthopaedic surgeries
  • Patients undergoing orthopaedic limb surgery with risk of compartment syndrome (i.e. acute supracondylar humerus fractures)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ochsner Medical Center

Jefferson, Louisiana, 70121, United States

Location

MeSH Terms

Conditions

Musculoskeletal Diseases

Interventions

Ropivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2020

First Posted

December 16, 2020

Study Start

June 24, 2021

Primary Completion

April 22, 2024

Study Completion

April 22, 2024

Last Updated

July 29, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations